Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells

Bone

Volumn 30, Issue 3, 2002, Pages 453-462

  O'Brien, C A ^a,c   Kern, B ^b   Gubrij, I ^a   Karsenty, G ^b   Manolagas, S C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cbfa1; Osteoblastogenesis; Osteoclastogenesis; Receptor activator of NF B ligand (RANKL)

Indexed keywords

LUCIFERASE; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; BINDING SITE; CELL SPECIFICITY; CONTROLLED STUDY; DNA FLANKING REGION; GENE ACTIVITY; GENE CONSTRUCT; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROMOTER REGION; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; STROMA CELL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OSTEOBLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; STROMAL CELLS; TRANSCRIPTION FACTORS;

EID: 0036196618     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00692-5     Document Type: Article

References (35)

1. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin
2. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
3. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo
4. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites
5. Dissociation between bone resorption and bone formation in osteopenic transgenic mice
6. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
7. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene
8. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
9. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
10. Potential role of Cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: Regulation of mRNA expression of osteoclast differentiation factor (ODF)
11. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells
12. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption
13. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
14. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1
15. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes
16. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene
17. Cloning and characterization of the gene encoding mouse osteoclast differentiation factor
18. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
19. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
20. Rapid and efficient site-specific mutagenesis without phenotypic selection
21. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
22. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR-gamma2
23. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
24. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
25. STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-kappa B ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone
26. Isolation and characterization of the human gp130 promoter. Regulation by STATS
27. Role of ascorbic acid in the osteoclast formation: Induction of osteoclast differentiation factor with formation of the extracellular collagen matrix
28. Osteoclast differentiation requires ascorbic acid
29. Overexpression of delta-FosB transcription factor(s) increases bone formation and inhibits adipogenesis
30. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
31. Cells of bone: Osteoclast generation
32. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function
33. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
34. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
35. 3 inhibits osteocalcin expression in mouse through an indirect mechanism